🇺🇸 FDA

Drug profile · INN

medroxyprogesterone acetate

MEDROXYPROGESTERONE ACETATE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

medroxyprogesterone acetate (MEDROXYPROGESTERONE ACETATE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN medroxyprogesterone acetate
Brand MEDROXYPROGESTERONE ACETATE
Route INJECTION
Formulation INJECTABLE
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 12403167

    Phenylethanoid glycoside extract from Acanthus ilicifolius L., preparation method thereof and use as anti-liver injury medicament

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12102688

    Immunomodulatory nanofilaments

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11730741

    6-chromanol derivatives for use as a medicament

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11701338

    Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross blood-brain barrier

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11699503

    Methods of identifying and treating patient populations amenable to cancer immunotherapy

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11135154

    Medroxyprogesterone acetate injectable compositions and methods of use

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11033550

    Medicament

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10857265

    Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use

    Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is medroxyprogesterone acetate?

medroxyprogesterone acetate (MEDROXYPROGESTERONE ACETATE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for medroxyprogesterone acetate?

MEDROXYPROGESTERONE ACETATE is a marketed brand name for medroxyprogesterone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of medroxyprogesterone acetate?

medroxyprogesterone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.